NEW YORK (AP) - HBO and Vice Media announced an expansion of their partnership on Thursday, including the launch of a daily Vice newscast on the pay cable outlet.
LONDON (AP) - British police are investigating a death threat made to the head of the BBC after the broadcaster fired "Top Gear" host Jeremy Clarkson over an assault on a colleague.
WASHINGTON (AP) - Talk of overhauling the criminal justice system is serious business - but before diving into the subject, President Barack Obama had something else he wanted to say.
LOS ANGELES (Variety.com) - Trevor Noah joined "The Daily Show" as a contributor only at the end of last year, but he could soon find himself serving as an integral part of the program.
Philly street performer Anthony Riley made history on The Voice when he received the TV show's fastest four-chair turn-around ever from the judges after an impassioned performance of James Brown's "I Got You (I Feel Good)."
VARIETY-ENTERTAINMENT-DIGITAL/NEWS:Is Cable's 'TV Everywhere' Strategy Finally Poised to Take Off?
PASADENA, Calif. (AP) - There's a mystery to cancer, in large part because of fear, that PBS tries to unravel in next week's six-hour documentary "Cancer: The Emperor of All Maladies."
The Walking Dead AMC's zombie ratings powerhouse wraps up its fifth season Sunday, as Rick and crew don't feel all too welcomed in the Alexandria safe zone, while Darryl runs into trouble out in the wild. It's a Walking Dead finale, so expect a death of a near and dear one. 9 p.m. Sunday on AMC.
Twice a year, like clockwork, religion visits the TV. Twice a year, we consume the same stories: the Nativity in December, the Exodus and the Passion of Christ in spring.
This time it's official: "Downton Abbey" will end next season.
The sweeping chronicle of cancer that premieres this week on PBS has strong Philadelphia connections. Cancer: The Emperor of All Maladies is famed documentarian Ken Burns' three-part, six-hour film adaptation of the Pulitzer Prize-winning, best-selling book. On Wednesday, the third and final episode prominently features a breakthrough immunotherapy being developed at the University of Pennsylvania and Children's Hospital of Philadelphia in partnership with pharmaceutical giant Novartis.